跳至主要内容
临床试验/NCT04357197
NCT04357197撤回不适用

Closed-loop Control of Vasopressor Infusion in Critically Ill Patients: A Case Series

Erasme University Hospital0 个研究点开始时间: 2020年9月25日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
主要终点
Percentage of case Time in hypotension (MAP <72 mmHg)

研究概览

简要总结

The purpose of this case series is to evaluate the performance of a novel closed-loop (automated) vasopressor administration system that delivers norepinephrine using feedback from standard hemodynamic monitor (EV1000 Monitor) from Edwards Lifesciences (IRVINE, USA) in critically ill patients

详细描述

In this protocol, the investigators will report the percentage of case time in hypotension (defined as Mean arterial pressure (MAP) < 72mmHg) during a two hours study protocol in critically ill patients.

The target MAP will be set at 80 mmHg, and the definition of hypotension is a MAP < 90% of MAP target ( 80 mmHg - 10% = 72 mmHg)

The investigators want to demonstrate that the closed-loop system can prevent hypotension at this specific set point.

The investigators will test the system in a short series of 10-12 critically ill patients in the ICU setting during a two hours study protocol.

Participants will receive standard patient care

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients in the intensive care unit (awake or under sedation)
  • Requiring norepinephrine to maintain a MAP of 80 mmHg
  • Equiped with an arterial line

排除标准

  • Subjects under 18 years of age
  • Subject with Atrial Fibrillation
  • Subjects who are pregnant

结局指标

主要结局

Percentage of case Time in hypotension (MAP <72 mmHg)

时间窗: During thetwo hours study protocol

The primary outcome will be the percentage of case time in predefined MAP target

次要结局

  • percentage of case time with MAP >88 mmHg with norepinephrine still running(During the two hours study protocol)
  • Amount of vasopressors received(During the two hours study protocol)

研究者

发起方
Erasme University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Alexandre Joosten, MD PhD

Principal Investigator

Erasme University Hospital

相似试验